2022-2029 年全球人體成分監測器市場

市場動態

肥胖患病率的上升和政府在促進健康生活方式方面的努力推動了身體成分測量市場的發展。

政府加大力度推廣健康的生活方式，推動了身體成分測量市場的發展。

為了解決超重的主要社會和環境決定因素以及潛在的不健康生活方式，世界各國已顯著擴大了政策行動。政府在解決生活方式行為和人民健康、減少健康不平等和慢性病方面可以發揮關鍵作用。政府參與包括監督、計劃、研究、質量保證、醫療保健以及飲食和身體活動 (PA) 指南。一些人將政府視為父權制，並支持個人選擇。但政府有機會跨部門開展工作，並讓私營部門參與整合各種方法。因此，政府促進健康生活方式的舉措將提高人們對使用身體成分分析儀來評估體內脂肪和無脂肪質量百分比的認識。

越來越多的肥胖患者將推動身體成分測量市場。

根據 A-Mansia Biotech 的數據，從 1975 年到 2020 年，全球肥胖患病率幾乎增加了兩倍。事實上，到 2020 年，將有超過 20 億成年人（佔全球成年人口的 39%）超重（BMI>25）。其中，超過 6 億人肥胖（BMI>30）。在歐洲，超過一半的人口超重（BMI>25），高達 30% 的人口肥胖（BMI>30）。此外，世界肥胖聯盟發布的《2022 年世界肥胖地圖集》預測，到 2030 年，將有 10 億人患有肥胖症，其中包括五分之一的女性和七分之一的男性。我來了。體重是肥胖最常用的指標。超重的人通常有更多的身體脂肪。體重的變化對應於體內水分、體脂肪和瘦肉組織的變化。身體成分是將您的身體分成其核心成分的一種方式：脂肪、礦物質、蛋白質和身體水分。與傳統方法相比，您可以更準確地描述您的體重，並更好地了解您的整體健康狀況。身體成分分析可以顯示脂肪量、肌肉量和體脂百分比的真實變化。既然您已經超出了 BMI（身體質量指數），那麼進行 BCA 有很多好處。健康比減肥更重要。有一些重要的因素，例如增加運動量和提高肌肉與脂肪的比例。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

與身體成分監測器相關的缺點抑制了它們的市場。

現代技術和評估有助於推進體脂分析，但仍存在某些缺點，尤其是取決於所選擇的方法。體脂分析方法的一個局限性是它只考慮了少數允許大量錯誤空間的區域。這個缺點可以通過重複使用同一個部位來觀察身體脂肪隨時間的變化來避免。生物電阻抗是一個不太完美的概念，因為它以如此高的速度運行，以至於損害了準確性。除了脂肪，你體內的水分含量也會影響你的反應時間，食物也是如此。

根據一個人的居住地，DEXA 掃描可能非常昂貴，以及周圍有多少中心、健身俱樂部和健康中心來攜帶必要的設備。這是先進的技術，您的社區或城鎮可能沒有太多選擇。

行業分析

Body Composition Monitor Market 根據未滿足的需求、定價分析、供應鏈分析和監管分析等各種行業因素對市場進行深入分析。

COVID-19 影響分析

預計 COVID-19 大流行將對市場產生相當積極的影響。正如一些研究表明的那樣，肥胖患者感染 COVID-19 的風險更高。此外，由於鎖門和居家令，人們比以前更久坐不動。因此，這推動了身體成分儀市場。

全球人體成分監測器市場報告提供大約 45 多個市場數據表、40 多個圖表和 180 頁內容。

內容

第 1 章研究方法與範圍

• 調查方法
• 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

• 按產品劃分的市場細分
• 最終用戶的市場細分
• 按地區劃分的市場細分

第 4 章市場動態

• 市場影響因素
  • 促進因素
    • 隨著肥胖患者數量的增加，身體成分分析儀的市場擴大
    • 政府增加促進健康生活方式的舉措推動了身體成分監測市場
  • 抑制因素
    • 與身體成分監測器相關的缺點阻礙了市場。
  • 機會
  • 影響分析

第 5 章行業分析

• 波特五力分析
• 流行病學分析
• 供應鏈分析
• 定價分析
• 監管分析
• 保險報銷分析
• 未滿足的需求

第 6 章 COVID-19 分析

• COVID-19 的市場分析
  • COVID-19 之前的市場情景
  • COVID-19 的當前市場情景
  • COVID-19 後或未來情景
• COVID-19 期間的價格動態
• 供需範圍
• 大流行期間與市場相關的政府舉措
• 製造商的戰略舉措
• 總結

第 7 章按產品分類

• 生物阻抗分析儀
• 雙能X射線吸收測量裝置
• 皮褶卡尺
• 空氣置換式體積描記裝置
• 其他

第 8 章最終用戶

• 醫院
• 健身俱樂部/健康中心
• 其他

第 9 章按地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 其他歐洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 其他亞太地區
• 中東和非洲

第 10 章競爭格局

• 主要發展和戰略
• 公司份額分析
• 產品基準
• 值得關注的重點公司
• 擁有顛覆性技術的公司
• 創業公司

第 11 章公司簡介

• GE Healthcare Inc.
  • 公司簡介
  • 產品組合和描述
  • 主要亮點
  • 財務摘要
• Bodystat
• Cosmed S.R.L
• Hologic Inc.
• Inbody Co. Ltd
• Jawon Medical Co. Ltd
• Maltron International Ltd
• Zhengzhou YKinspection Enterprise Co., Ltd.
• Chongqing Xishan Science & Technology Co., Ltd
• Guangzhou Lety Medical Limited（*LIST NOT EXHAUSTIVE）

第 12 章DataM

Market Overview

Body Composition Analyzers Market is estimated to reach at a CAGR of 11.2% during the forecast period (2022-2029).

The body composition analyzer works based on bioelectrical impedance analysis (BIA). A method of measuring impedance by applying alternate electrical currents to a user, measuring their volume of water through impedance values, is known as bioelectrical impedance analysis. Body composition analysis can accurately show changes in muscle mass, body fat percentage, and fat mass.

Market Dynamics

The increasing population of obese patients and increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market.

Increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market.

In an attempt to solve some of the key social and environmental determinants of overweight and its underlying unhealthy lifestyles, countries worldwide have significantly up-scaled their policy actions. The government plays an important role in addressing lifestyle behaviors and population health, reducing health disparities and chronic disease. Government involvement includes surveillance, programming, research, quality assurance, access to health care, and guidelines for diet and physical activity(PA). Some view government as paternalistic and favor individual choice. However, there is an opportunity to unite diverse approaches with the government working across sectors and engaging the private sector. Hence, the government's initiatives to promote a healthy lifestyle will increase the awareness of the use of body composition analyzers to assess the proportion of fat to fat-free mass in the body.

The increasing population of obese patients will drive the body composition analyzers market.

According to A-Mansia Biotech, Worldwide prevalence of obesity the worldwide prevalence of obesity nearly tripled between 1975 and 2020. In fact, in 2020, more than 2 billion adults (39% of the global adult population) were overweight (BMI > 25). Of these, over 600 million were obese (BMI > 30). In Europe, more than half the population is overweight (BMI > 25), and up to 30% are obese (BMI > 30). Moreover, the World Obesity Atlas 2022, published by the World Obesity Federation, expects that one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030. The most frequently used measure of obesity is body weight. In general, people with high body weights have higher amounts of body fat. Weight changes correspond to body water, fat, and lean tissue changes. Body composition is a method in which the body is divided into its core components: fat, minerals, protein, and body water. It describes weight more accurately and provides a better look into overall health than traditional methods. Body composition analysis can show real changes in fat mass, muscle mass, and body fat percentage. There are many benefits of doing a BCA now that it has surpassed the outdated Body Mass Index (BMI). There is more to being healthy than losing weight. There are important factors like increasing physical activity and improving the muscle-to-fat ratio. Thus, from the above statements, the market is expected to drive in the forecast period.

Disadvantages related to body composition analyzers will hamper its market.

Although modern technologies and assessment have helped evolve body fat analysis, there are still certain shortcomings, especially depending on the chosen method. The limitation of the method of body fat analysis is that it considers only a few areas that give room for substantial errors. This shortcoming can be avoided if the same area is used repeatedly to check the increase or decrease in body fat over time. Bioelectrical impedance is not very accurate as it works fast, which compels a compromise on accuracy, which makes the concept not so perfect. Other than fat, hydration levels in the body would also influence the response time, food, and other factors.

Depending on where one lives, DEXA scans can be quite expensive and how many centers or Fitness Clubs & Wellness Centers are around to carry the equipment needed. This is an advanced technology, and one may not have many options in a neighborhood or town.

Industry Analysis

The body composition analyzers market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

COVID-19 pandemic is expected to have a fairly positive impact on the market. As suggested by some studies, the risk of contraction of COVID-19 is more in obese patients. Additionally, with lockdown and staying at home, people have become more sedentary than before. Hence, this will drive the body composition analyzers market.

Segment Analysis

The Bio-impedance analyzer segment is expected to hold the largest market share in the body composition analyzers market.

The bio-impedance analyzer segment accounted for the largest share in 2021. It is a method of assessing body composition known as Bioimpedance Analysis (BIA). It is the measurement of body fat in relation to lean body mass. One integral part of a health and nutrition assessment is BIA. It also provides a measurement of fluid and body mass that can be a critical assessment tool for the current state of health. This non-invasive test involves the placement of two electrodes on the right hand and foot of a person. An imperceptible low-level electrical current is sent through the body, and the amount of water in the body will affect the current flow. The device measures how this signal is delayed through different types of tissue. Tissues that contain large amounts of fluid and electrolytes, such as blood, have high conductivity, but fat and bone slow the signal down. The resistance to the flow of the current passing through the body is determined by BIA, which estimates body water from which body fat is calculated using selected equations. For instance, bodivis BCA-2A records key body composition indexes accurately and shows changes like muscle mass, protein, body water and body fat percentage. This can help by validating patient care, corporate wellness and personal training. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

The hospital's segment is expected to hold the largest market share in the body composition analyzers market.

Hospitals with their large scale, strong financial capabilities, and broad range of services will see an increase in this segment. To provide a long-term solution for the treatment of obese individuals, the procedures must be simple and safe to perform, with the device's efficacy maintained throughout long treatment durations. This non-invasive technique involves the placement of electrodes on the feet, hands, or both of a person. An electrical current of low-level is sent through the body, and the current flow is affected by the amount of body water. BIA device measures this signal impeded through different tissue types (muscle has high conductivity, but fat slows the signal down). To reduce the risk of these devices, it's better to use them in a hospital setting. Hospitals provide the best medical practitioner and advanced medical devices. Hence, this segment will dominate the market.

Geographical Analysis

North American region is expected to hold the largest market share in the global body composition analyzers market.

The North American region accounted for the largest market share in 2021. The region's growth is attributed to the increasing prevalence of obesity, and rising product launches by the market players are some factors expected to boost the region in the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), the proportion of US children, who are overweight or obese, which has climbed steadily for years, surged to unprecedented levels during the pandemic. Among a cohort of 432 302 people aged 2-19 years, the body mass index (BMI) increase roughly doubled during the pandemic compared with the preceding period. The greatest increases were seen in children aged 6-11 and those already overweight before the pandemic.

Moreover, the Centers for Disease Control and Prevention reported that the number of states in which at least 35% of residents self-report obesity increased in 2020 from 12 to 16 and therefore, the US is the world's most overweight large country, with an average BMI of 26.6 in men and 26.5 in women. Therefore, it has increased the demand for body composition analyzers. Additionally, at CES Las Vegas in January 2020, Inbody USA will formally debut the InBody 970. The InBody 970, when used in conjunction with the Yscope, analyses and categorizes abdominal fat and total body water using new patented technology. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the body composition analyzers market are Bodystat, Cosmed S.R.L, GE Healthcare Inc., Hologic Inc., Inbody Co. Ltd, Jawon Medical Co. Ltd, Maltron International Ltd, Omron Healthcare Inc., Seca GmbH & Co. Kg., and Tanita Corporation, Zhengzhou YKinspection Enterprise Co., Ltd., Chongqing Xishan Science & Technology Co., Ltd, Guangzhou Lety Medical Limited.

InBody Co Ltd:

Overview:

InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.

Product Portfolio:

InBody 270: The portable and precise InBody 270 body composition analyzer provides accurate analysis for professionals on the go. Delivers standard measurements like Percent Body Fat, Skeletal Muscle Mass, BMR, and more.

The global body composition analyzers market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet By Product
• 3.2. Market Snippet By End User
• 3.3. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The increasing population of obese patients will drive the body composition analyzers market
    • 4.1.1.2. Increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market
  • 4.1.2. Restraints:
    • 4.1.2.1. Disadvantages related to body composition analyzers will hamper its market
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Epidemiology Analysis
• 5.3. Supply Chain Analysis
• 5.4. Pricing Analysis
• 5.5. Regulatory Analysis
• 5.6. Reimbursement Analysis
• 5.7. Unmet Needs

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.1.2. Market Attractiveness Index, By Product Segment
• 7.2. Bio-impedance Analyzer *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
• 7.3. Dual Energy X-ray Absorptiometry Equipment
• 7.4. Skinfold Calipers
• 7.5. Air Displacement Plethysmography Equipment
• 7.6. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 8.1.2. Market Attractiveness Index, By End User Segment
• 8.2. Hospitals *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
• 8.3. Fitness Clubs & Wellness Centers
• 8.4. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Key Developments and Strategies
• 10.2. Company Share Analysis
• 10.3. Product Benchmarking
• 10.4. Key Companies to Watch
• 10.5. Company with disruptive technology
• 10.6. Start Up Companies

11. Company Profiles

• 11.1. GE Healthcare Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Bodystat
• 11.3. Cosmed S.R.L
• 11.4. Hologic Inc.
• 11.5. Inbody Co. Ltd
• 11.6. Jawon Medical Co. Ltd
• 11.7. Maltron International Ltd
• 11.8. Zhengzhou YKinspection Enterprise Co., Ltd.
• 11.9. Chongqing Xishan Science & Technology Co., Ltd
• 11.10. Guangzhou Lety Medical Limited(*LIST NOT EXHAUSTIVE)

12. DataM Intelligence

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us